Zimmer Biomet Holdings, INC Form 4 insider transactions

NYSE
Director Maria Teresa Hilado reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.
NYSE
Director Robert Hagemann reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.
NYSE
Director Michael J. Farrell reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.
NYSE
Director Christopher B. Begley reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Devdatt Kurdikar reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Wilfred van Zuilen, Group President EMEA at Zimmer Biomet, reports the vesting of restricted stock units and subsequent tax withholding.
NYSE
Director Devdatt Kurdikar acquired phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Christopher B. Begley reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Michael J. Farrell reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Robert Hagemann reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan.
NYSE
Director Syed A. Jafry reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Maria Teresa Hilado reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Louis Shapiro reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Kolli Sreelakshmi reported the acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reported the sale of 12,857 shares of common stock on May 31, 2024.
NYSE
Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent tax withholding.
NYSE
Director Louis Shapiro reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Director Michael Michelson reports acquisition of phantom stock units and restricted stock units under Zimmer Biomet's deferred compensation plan.
NYSE
Director Sreelakshmi Kolli reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Director Syed A. Jafry reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Director Maria Teresa Hilado reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Director Robert Hagemann reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Director Betsy J. Bernard reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Director Michael J. Farrell reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Director Christopher B. Begley reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Director Arthur J. Higgins reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.
NYSE
Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent tax withholding.
NYSE
Director Michael W. Michelson reported the acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the company's deferred compensation plan.